On May 9, 2024, AREX Capital Management, LP announced that it has issued statement expressing its disappointment in the conclusion of Enhabit?s strategic review without a sale of the Company and views that this failure reflects the Company?s intrinsic value or strategic potential. AREX Capital stated that in March, it has nominated a slate of 7 candidates: Megan Ambers, James T. Corcoran, Maxine Hochhauser, Mark W. Ohlendorf, Anna-Gene O?Neal, Dr. Gregory S. Sheff, Juan Vallarino to stand for election at the 2024 Annual Meeting and chose not to publicly disclose its nomination to avoid disrupting the strategic review process to the detriment of shareholders, but clearly it hopes that this Board might finally deliver a positive result for its shareholders was wishful thinking. AREX Capital added that the Company?s lackluster operating performance relative to peers over the past two years plainly demonstrates that the Board urgently needs the deep operational expertise in home health and hospice that the AREX Slate would bring who are eager to begin the work of driving improvement at the Company and maximizing value for all shareholders.